Dalrada (DFCO) Appoints Gregory L. Remsen To Vice President of Strategic Relationships.
Dalrada Financial Corporation Appoints Gregory L. Remsen To Vice President of Strategic Relationships
DALRADA NEWS ARCHIVE
Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines Affordable Worldwide.
Dyadic International, Inc. (NASDAQ: DYAI) – We are a global biotechnology company focused on further improving and leveraging the patented and proprietary...
OmniQ (OMQS) Lands Another $6.6 Million in New Orders.
OMNIQ Receives $6.6 Million in New Orders from a Leading U.S. Supermarket Chain for "Touchless" Real-time Data Collection and Analysis Solutions
Dalrada (DFCO) Finally Pops. Up 59% Today.
Up 59% today on news and with 4 million shares trading and counting!
LIVE QUOTE
Adding Hapbee (HAPB) to the Watch List.
Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee’s (HAPB) Device, “Choose How You Feel.”
HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL'
Proprietary, Research-Backed...
Citius (CTXR) Announces Results of Mino-Lok Study.
"Mino-Lok has the potential to change the standard of care, which currently calls for a procedure to remove and replace the infected...
Kevin Harrington Presentation. (Video)
The Three Strategies I've Used to Build Businesses.
https://youtu.be/aNZAAKxPNlM
Shark Tanks’ Kevin...
Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...
PITTSFORD, N.Y., Nov. 12, 2020
PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
